Progenics Pharmaceutical Inc
PGNX · Chemicals & Drugs · NASDAQ · in our data November 19, 1997 to June 19, 2020 (22.6 years)
The first trading day in our data for Progenics Pharmaceutical Inc is November 19, 1997 (its first day in our records, which may be later than its listing and is not its founding). At its peak, on February 28, 2000, the market valued it at $1.1 billion. It ended in a collapse: the last trade was $4.10, -95.6% from its split-adjusted high. The delisting record says: merged or acquired.
Share prices are adjusted for splits and other share changes, so the high and the last price compare like for like; the peak market value is as it was on the day. The return covers the trading days in our data only: it does not include what holders received, or lost, after the last trade (a merger payout, a bankruptcy), and it does not reach back before 1997.
Could you have seen it coming? Play COVIDAlso gone in 2020: Chemicals & Drugs
- Avon Products peaked at $21.8 billion
- Immunomedics Inc peaked at $20.3 billion
- Myokardia Inc peaked at $12.0 billion
- Medicines Co (the) peaked at $6.8 billion
- Akorn Inc peaked at $6.4 billion
- PDL Biopharma Inc peaked at $6.3 billion
